IRIS
DURANTI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.321
EU - Europa 9.677
AS - Asia 5.886
SA - Sud America 524
Continente sconosciuto - Info sul continente non disponibili 284
AF - Africa 71
OC - Oceania 38
Totale 32.801
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.058
CN - Cina 2.821
GB - Regno Unito 2.629
IT - Italia 2.200
SG - Singapore 1.663
UA - Ucraina 1.375
SE - Svezia 710
RU - Federazione Russa 678
FI - Finlandia 553
TR - Turchia 500
DE - Germania 469
BR - Brasile 389
FR - Francia 353
IE - Irlanda 333
VN - Vietnam 319
CA - Canada 145
IN - India 144
PL - Polonia 85
NL - Olanda 75
HK - Hong Kong 67
BD - Bangladesh 66
JP - Giappone 63
KR - Corea 59
MX - Messico 47
AR - Argentina 43
ES - Italia 43
AU - Australia 31
AT - Austria 27
BE - Belgio 26
IQ - Iraq 26
ZA - Sudafrica 26
LT - Lituania 24
ID - Indonesia 23
CL - Cile 19
CO - Colombia 19
IR - Iran 14
PK - Pakistan 14
EC - Ecuador 13
AE - Emirati Arabi Uniti 12
JM - Giamaica 12
MY - Malesia 12
VE - Venezuela 12
CH - Svizzera 11
CR - Costa Rica 11
PE - Perù 11
SA - Arabia Saudita 11
HN - Honduras 10
UZ - Uzbekistan 10
MA - Marocco 9
HR - Croazia 8
HU - Ungheria 8
JO - Giordania 8
PY - Paraguay 8
RO - Romania 8
EU - Europa 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
PH - Filippine 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
BG - Bulgaria 6
GR - Grecia 6
GT - Guatemala 6
IL - Israele 6
KE - Kenya 6
SV - El Salvador 6
TN - Tunisia 6
EG - Egitto 5
NI - Nicaragua 5
SM - San Marino 5
TH - Thailandia 5
TW - Taiwan 5
AZ - Azerbaigian 4
BO - Bolivia 4
BY - Bielorussia 4
CW - ???statistics.table.value.countryCode.CW??? 4
DK - Danimarca 4
DZ - Algeria 4
EE - Estonia 4
KG - Kirghizistan 4
PR - Porto Rico 4
UY - Uruguay 4
AM - Armenia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GP - Guadalupe 3
LU - Lussemburgo 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
PA - Panama 2
AD - Andorra 1
AL - Albania 1
Totale 32.502
Salva come PNG Salva come JPEG
Città #
Southend 2.316
Woodbridge 1.679
Ann Arbor 1.245
Ashburn 1.228
Houston 1.132
Jacksonville 1.094
Fairfield 1.052
San Jose 958
Chandler 894
Singapore 859
Nanjing 557
Dallas 501
Cambridge 476
Wilmington 449
Seattle 437
Beijing 430
Izmir 345
Council Bluffs 316
Boardman 282
Dublin 272
Urbino 255
Helsinki 236
Nanchang 192
New York 190
San Mateo 169
Lauterbourg 165
Princeton 162
Los Angeles 149
Santa Clara 132
Hebei 118
Shenyang 118
Milan 100
Changsha 98
Jiaxing 97
Ho Chi Minh City 96
Istanbul 92
Tianjin 87
Velikiy Novgorod 82
Rome 81
Buffalo 68
Hanoi 68
Düsseldorf 67
Hong Kong 65
Munich 59
Toronto 59
Kunming 57
San Francisco 57
Seongnam 52
Chicago 50
São Paulo 50
London 49
Menlo Park 48
Moscow 48
San Diego 47
Dong Ket 46
Bremen 43
Shanghai 42
Nuremberg 38
Atlanta 35
Guangzhou 35
Hangzhou 35
Stockholm 35
Warsaw 35
Frankfurt am Main 34
Denver 33
Jinan 33
Mülheim 32
Des Moines 31
Kraków 30
Montreal 30
Orem 30
Tokyo 29
Changchun 28
Phoenix 28
Naples 26
Mumbai 25
Brussels 24
Chennai 24
Brooklyn 23
Charlotte 23
Ningbo 23
The Dalles 23
Lanzhou 22
Mexico City 22
Ancona 21
Palermo 21
Manchester 20
Napoli 19
Norwalk 19
Amsterdam 18
Dearborn 18
Turin 18
Zhengzhou 18
Bologna 17
Haikou 17
Leawood 17
Taizhou 17
Ankara 16
Florence 16
Hefei 16
Totale 21.190
Salva come PNG Salva come JPEG
Nome #
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 882
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 882
Derivatizzazione one-pot di indoli per la sintesi di triptofani, pirroloindoline, bis-indoli & co 506
Unsaturated fatty acids lactose esters: cytotoxicity, permeability enhancement and antimicrobial activity 429
Pharmacokinetics, pharmacodynamics and safety studies on URB 937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats 380
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 367
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 320
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 307
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 296
Antitumoral activity of indole-3-carbinol cyclic tri- and tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies 296
A New Synthesis of 2-Substituted DL-Tryptophan Derivatives 293
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 293
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis, Binding Affinity for Melatonin Receptor, and Evaluation of the Biological Activity 292
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 291
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus 283
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 276
Lactose oleate as new biocompatible surfactant for pharmaceutical applications 272
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 271
A combination of sugar esters and chitosan to promote in vivo wound care 268
2-Bromomelatonin: Synthesis and characterization of a potent melatonin agonist 266
The Synthetic Cannabinoid URB447 Reduces Brain Injury and the Associated White Matter Demyelination After Hypoxia-Ischemia in Neonatal Rats 262
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 261
Synthesis, Structure-Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability Enhancers 257
Synthesis and Evaluation of Saccharide-Based Aliphatic and Aromatic Esters as Antimicrobial and Antibiofilm Agents 254
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 250
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 250
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 248
Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines 242
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 240
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 240
An endocannabinoid mechanism for stress-induced analgesia 234
A practical and expeditious method for the preparation of the anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 231
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats 231
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 228
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 223
Indole-3-carbinol (I3C) Tetrameric Derivative (CTet) Inhibits Cell Cycle Progression Inducing Overexpression of p21/cip1/waf1 and GADD45A in Breast Cancer Cell Lines 222
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 221
Peripherally Restricted FAAH Inhibitors 221
The indole-3-carbinol tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines 219
Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanyl Carbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors 218
A Versatile Biomimetic Approach to Diindolylmethane Derivatives as Potential Anticancer Agents 216
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis and Binding Affinity to the Melatonin Receptor 213
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 213
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 210
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 210
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 209
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 207
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 206
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 205
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 201
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 200
Modulation of anxiety through blockade of anandamide hydrolysis 200
N-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis, Structure–Activity and Structure–Property Relationships 198
Antimyotonic effects of enantiomers of mexiletine-like drugs 197
Therapeutic Effects of Tocainide and Mexiletine Analogs on Myotonic MTO and ADR Mice 197
Derivato tetramerico ciclico dell’indol-3-carbinolo CTet come chemiopreventivo in tumori al seno estrogeno-dipendenti 196
SYNTHESIS AND EVALUATION OF SUGAR-BASED ALIPHATIC AND AROMATIC FATTY ACID ESTERS AS ANTIMICROBIAL AND ANTIBIOFILM AGENTS 196
α-Acylamino-β-lactones as a new class of N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitors: synthesis and structure–activity relationships 195
Synthesis and Structure–Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors 195
Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring 194
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 193
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice 191
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 191
The CB1 Antagonist/CB2 Agonist URB447 Confers Neuroprotection after Neonatal Hypoxia-ischemia 190
Synthesis and Structure–Activity Relationship Studies of O-Biphenyl-3-yl Carbamates as Peripherally Restricted Fatty Acid Amide Hydrolase Inhibitors 190
Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597) 189
The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues 189
Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels 188
Sintesi e studi di relazione struttura–attività/selettività su O-bifenil-3-ilcarbammati disostituiti quali inibitori periferici dell’enzima FAAH 188
Synthesis and Structure-Activity/Stability Relationships of Carbamate Inhibitors of the FAAH Enzyme 187
Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition 187
The collisional behavior of ESI-generated protonated molecules of some carbamate FAAH inhibitors isosteres and its relationships with biological activity 186
Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors 184
N-alchil-O-arilcarbammati come inibitori delle idrolasi delle ammidi degli acidi grassi (FAAH): aspetti meccanicistici 182
A linear relationship between MS/MS data and FAAH inhibitory activity of some carbamates 180
Identification of a Bioactive Impurity Present in a Sample of URB754 176
Analoghi chirali della mexiletina: attività sui canali ionici 175
Selective inhibition of 2 - AG hydrolysis enhances endocannabinoid signaling in the hippocampus 174
Synthesis and Biological Characterization of the New Glycolipid Lactose Undecylenate (URB1418) 172
Contribution to the Study of 2-Aryloxy-1-phenyl and 2-Aryloxy-2-phenylethanols. Differentiation by Mass Spectrometry 169
3D-QSAR study of carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 169
Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3'-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation 168
Stereospecific synthesis of mexiletine and related compounds: Mitsunobu versus Williamson reaction 167
Synthesis and Biological Evaluation of 6-O-Sucrose Monoester Glycolipids as Possible New Antifungal Agents 167
2,6-Xilididi e β-2,6-xililossietilammine come ligandi anfipatici per i recettori benzodiazepinici di tipo mitocondriale 166
Design, SAR and Biological Activity of a New Class of FAAH Inhibitors: Cyclohexyl Carbamic Acid Biphenyl-3-yl Esters 162
Antinociceptive effects of the brain-impermeant fatty-acid amide hydrolase inhibitor URB937 162
Antinoceptive Effects of the N-Acylethanolamine Acid Amidase Inhibitor ARN077 in Rodent Pain Models 160
Synthesis and pharmacological characterization of URB447, a new cannabinoid receptor neutral antagonist 159
Relationships Between Mass Spectrometry and Biological Stability of Some N-Acylethanolamine Acid Amidase Inhibitors 158
QSAR and molecular modelling investigations of a new series of alkyl carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 157
Inhibitors of lysosomal lipid amidase NAAA 156
Tandem mass spectrometric data–FAAH inhibitors activity relationships of some carbamic acid O-aryl esters 155
Anestetici locali (Cap. 14) 155
Chronic stimulation of the endogenous anandamide tone reduces cocaine-seeking and cue-induced relapse in rats 153
Structure-Activity Relationships of Alkylcarbamic Acid Aryl Esters, as Fatty Acid Amide Hydrolase Inhibitors 151
Total Synthesis of Natural Disaccharide Sambubiose 151
URB602, a Monoacylglycerol Lipase Inhibitor, Protects from the Long-term Consequences of a Neonatal Hypoxic-ischemic Brain Injury in Rats 150
Design, Synthesis and SAR of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acids Amide Hydrolase Inhibitors 150
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 149
Totale 23.126
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.245 0 0 0 183 71 41 83 97 121 99 47 503
2022/20232.761 312 129 65 357 215 574 42 241 467 93 149 117
2023/2024781 96 54 56 91 54 166 37 49 15 66 28 69
2024/20252.662 139 140 619 204 97 192 296 152 244 160 237 182
2025/20266.724 538 724 779 1.069 508 457 868 264 446 533 352 186
2026/20272.097 846 189 621 441 0 0 0 0 0 0 0 0
Totale 32.801